Cardiovascular

Latest News

Nurse using stethoscope on older patient | Image credit: InsideCreativeHouse – stock.adobe.com

Is Frailty Index the Most Accurate Predictor of CVD?

By Hayden E. Klein

May 9th 2025

A study comparing biological aging indicators found that Rockwood Frailty Index was a stronger predictor of cardiovascular disease (CVD) than leukocyte telomere length in adults without prior CVD.

Antoine Keller, MD

Striving for Health Equity: Antoine Keller, MD

By Kyle Munz
Antoine Keller, MD, FACC, FACS

May 9th 2025

Effect of Remote Patient Monitoring on Stage 2 Hypertension

Effect of Remote Patient Monitoring on Stage 2 Hypertension

By Lyle Dennis, MD
Irina Koyfman, DNP, NP-C, RN

May 6th 2025

Q&A with Sid Patel, MD

Abelacimab Demonstrates Safety and Efficacy for Patients With AFib of All Ages: Sid Patel, MD

By Kyle Munz
Siddharth M. Patel, MD, MPH

April 24th 2025

One's ZIP code can greatly influence care access | image credit: Syda Productions - stock.adobe.com

"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health

By Kyle Munz
Antoine Keller, MD, FACC, FACS

April 18th 2025

Lipoprotein(a) and Cardiovascular Risk

Learn about more about lipoprotein(a), including how to improve patient outcomes through better screening and management.

Continuing Medical Education

May 14th 2025

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases

May 14th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

May 14th 2025

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology

More News

Horizon BCBSNJ Reports 10% Rise in Value-Based Payments

October 3rd 2018

Horizon BCBSNJ Reports 10% Rise in Value-Based Payments

For 2017, New Jersey's largest insurer made particularly good progress in certain diabetes measures and in cancer screenings.

Family History Linked With Early-Onset Atrial Fibrillation in Black and Latino Patients

September 25th 2018

Family History Linked With Early-Onset Atrial Fibrillation in Black and Latino Patients

Black and Latino individuals are less likely than their white peers to develop early-onset atrial fibrillation (EOAF), yet these individuals experience higher rates of stroke, heart failure, and mortality from AF than do white patients. To date, little has been known about this paradox, as most research into EOAF focuses on white patients.

September 24th 2018

MitraClip Reduces Hospital Stays, Deaths Among Patients With Heart Failure

Heart failure hospitalization has been a target for accountable care organizations seeking to find ways to cut costs from the healthcare system. But it remains to be seen how many of the estimated 2 million patients would gain access to the device if it received an expanded indication and payer coverage.

Diabetes Drug Farxiga Cuts Heart Risks in Topline Results

September 24th 2018

Diabetes Drug Farxiga Cuts Heart Risks in Topline Results

Full results from the cardiovascular outcomes trial for dapagliflozin (Farxiga) will be presented at the American Heart Association annual meeting in November.

US Women Have Higher Risk of Dying Prematurely, Report Says

September 21st 2018

US Women Have Higher Risk of Dying Prematurely, Report Says

Allison Inserro

In the United States, a woman age 30 to 70 years of age has a 1 in 8 chance of dying from a noncommunicable disease (NCDs), putting the nation on par with low and middle-income countries, and setting it apart with Iceland among high-income countries, according to a report published Thursday in The Lancet.

September 17th 2018

Low-Dose Aspirin Won't Prolong Life in Healthy Older People, Study Announces

The study by the National Institute on Aging produced a few surprises and was stopped early when aspirin showed no benefit.

An Apple Watch Can Now Take Your EKG

September 12th 2018

An Apple Watch Can Now Take Your EKG

The announcement comes with word from FDA touting the effectiveness of its efforts to advance digital health regulatory pathways.

FDA to Review Application for CV Indication for Praluent

September 12th 2018

FDA to Review Application for CV Indication for Praluent

The application is based on results presented in March at the 67th Scientific Session of the American College of Cardiology.

GLP-1 Drugs Not Associated With Increased Risk of Diabetic Retinopathy, Study Finds

August 29th 2018

GLP-1 Drugs Not Associated With Increased Risk of Diabetic Retinopathy, Study Finds

The analysis of patient records found no elevated risk of retinopathy among those using glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes.

ASCEND Results Confirm Aspirin Prevents Primary Vascular Events in Diabetes

August 27th 2018

ASCEND Results Confirm Aspirin Prevents Primary Vascular Events in Diabetes

Surabhi Dangi-Garimella, PhD

Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ongoing ESC Congress in Munich, Germany.

What We're Reading: Protections for Pre-existing Conditions; Shareholders Approve Cigna–Express Scripts Deal; Aspirin and CV Risk

August 27th 2018

What We're Reading: Protections for Pre-existing Conditions; Shareholders Approve Cigna–Express Scripts Deal; Aspirin and CV Risk

GOP senators have introduced legislation they say would protect provisions for preexisting conditions under the Affordable Care Act; Cigna shareholders have voted in favor of the acquisition of pharmacy benefit manager Express Scripts; and study results show that aspirin does not lower cardiovascular (CV) risk in the long-term.

August 24th 2018

Drug Prices Not Consistently Aligned With Value, Analysis Finds

Jaime Rosenberg

A Health Affairs analysis showed a wide range of cost-effectiveness estimates for 30 of the most commonly prescribed cardiovascular drugs, suggesting that drug pricing is not consistently aligned with value.

AJMC® in the Press, August 10, 2018

August 10th 2018

AJMC® in the Press, August 10, 2018

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

August 10th 2018

Patient and Physician Predictors of Hyperlipidemia Screening and Statin Prescription

Sneha Kannan, MD David A. Asch, MD, MBA Gregory W. Kurtzman, BA Steve Honeywell Jr, BS Susan C. Day, MD, MPH Mitesh S. Patel, MD, MBA, MS

Physician and patient predictors of hyperlipidemia screening and statin prescription at a large, multihospital regional health center based on electronic health record data.

Oncology, CVD, Infectious Disease Most Common Areas for Outcomes-Based Contracts, Avalere Finds

July 27th 2018

Oncology, CVD, Infectious Disease Most Common Areas for Outcomes-Based Contracts, Avalere Finds

Laura Joszt, MA

Health plans continue to show interest in expanding outcomes-based contracts, according to an Avalere Health study that also found cardiovascular diseases, infectious diseases, and oncology represent the most common therapeutic areas to have these contracts.

Swapping Metformin for Sulfonylureas Boosts CV Risk in Type 2 Diabetes, Study Finds

July 19th 2018

Swapping Metformin for Sulfonylureas Boosts CV Risk in Type 2 Diabetes, Study Finds

Sulfonylureas are an older class of type 2 diabetes therapy but remain the most commonly prescribed antidiabetic drug after metformin.

July 12th 2018

Direct Oral Anticoagulant Prescription Trends, Switching Patterns, and Adherence in Texas Medicaid

Shui Ling Wong, MS Landon Z. Marshall, PharmD Kenneth A. Lawson, PhD

Direct oral anticoagulants (DOACs) are associated with increased prescription costs. Actual practice data show a high switch rate and poor adherence among DOAC initiators that need to be addressed.

June 29th 2018

Population-Level Health Initiatives Can Improve Health and Reduce Risk of Heart Disease in a Community

Laura Joszt, MA

Findings from a 10-year research project show that implementing health initiatives at a population level can improve health and reduce the risk of heart disease for an entire community.

June 4th 2018

Want to Live Longer? Pick Up the Pace, Study Says

Public health messaging has typically focused on the volume of walking not the intensity. This study suggests for those with limited time, a faster pace could make a difference.

May 23rd 2018

Under 2017 Guideline, More Than 105 Million Americans Have Hypertension

The number of US adults who have high blood pressure could grow by as much as 31 million—and the number of adults who will be recommended for antihypertensive treatment could increase by 11 million—if full implementation of the American Heart Association’s 2017 hypertension guideline is reached.

May 16th 2018

Quality of Cardiovascular Care May Vary Substantially Across the VA System

The authors write that these differences among Veterans Affairs (VA) populations could reflect variability across the medical centers in terms of quality of care, adherence to evidence-based treatment and screening guidelines, access to urgent care, posthospitalization care protocols, chronic disease management, and access to specialty care, social work services, and behavioral health care.

5 Things to Know About the Praluent–Express Scripts Deal

May 4th 2018

5 Things to Know About the Praluent–Express Scripts Deal

This week's announcement comes after cardiologists have spent several years sharing accounts of their difficulty gaining access to PCSK9 inhibitors for their patients.

May 2nd 2018

Women Are Still Underrepresented in Clinical Trials for Cardiovascular Disease Drugs

While cardiovascular disease (CVD) is the leading cause of death among women as well as men, and while both sex and gender differences in CVD and its treatments have been well documented, women continue to be less represented than men in clinical trials of drugs to treat CVD. Among proposed reasons for this phenomenon are the recruitment of younger patients, inclusion criteria that tend to select men, and exclusion criteria that are more common in women.

Research Provides Insight Into Cardiac-Related Mortality in Huntington Disease

May 1st 2018

Research Provides Insight Into Cardiac-Related Mortality in Huntington Disease

Huntington disease (HD) is an incurable, inherited neurological disorder caused by the mutant Huntingtin gene, which produces a mutant form of Huntingtin protein (mHTT). In addition to creating the profound neurological impacts of HD, the mHTT protein also impairs other organ systems, and new research, published in Cell Reports, suggests that the protein may play a role in cardiac-related mortality in patients with HD.

Women With Migraine More Likely to Develop Hypertension

April 30th 2018

Women With Migraine More Likely to Develop Hypertension

Jaime Rosenberg

Women with a past history of migraine have a 15% higher risk of developing hypertension than those with no history of migraine, according to study findings published in Cephalalgia.

April 23rd 2018

JAMA Comparison: SGLT2 Inhibitors, GLP-1 Agonists Offer Lower Mortality in Type 2 Diabetes

Guidance for primary care physicians prescribing type 2 diabetes therapies comes at an opportune time. A major rift over guidelines for glycemic control has opened between the American College of Physicians, a professional association of internists, and diabetes specialists, including endocrinologists and diabetes educators.

April 19th 2018

Marital Status and SES Associated With Higher Risk of Second Heart Attack, Stroke

Laura Joszt, MA

Divorce and socioeconomic status (SES)—measured by disposable income and education—predict patients who survived a heart attack who are at higher risk of a second event.

Reports Highlight Impact of Taxing Unhealthy Products to Combat Chronic Diseases Worldwide

April 11th 2018

Reports Highlight Impact of Taxing Unhealthy Products to Combat Chronic Diseases Worldwide

Laura Joszt, MA

Papers from The Lancet's Taskforce of Non-Communicable Diseases analyzed the potential health and economic impact of implementing taxes on soda, alcohol, and tobacco to combat the rising rates of the chronic diseases worldwide.

March 19th 2018

Semaglutide Produces Significant, Sustained Weight Loss for Adults With Obesity in Phase 2 Trial

The study compared patients taking semaglutide with those taking placebo and liraglutide, which is approved for treatment of obesity.

5 Takeaways From the American College of Cardiology Scientific Session

March 16th 2018

5 Takeaways From the American College of Cardiology Scientific Session

Results from the ODYSSEY Outcomes trial for the PCSK9 inhibitor alirocumab were the top news at the meeting.

...

8 9 10 11 12 13 14 15 16

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions